Skip to content

Therapeutic Controlled Hypothermia in the Treatment of Neonates With Severe Necrotizing Enterocolitis

Therapeutic Controlled Hypothermia in the Treatment of Neonates With Severe Necrotizing Enterocolitis

Status
Terminated
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01330576
Acronym
CoolNEC
Enrollment
13
Registered
2011-04-07
Start date
2010-08-02
Completion date
2013-03-25
Last updated
2022-02-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Necrotizing Enterocolitis

Keywords

Hypothermia, cooling, necrotizing enterocolitis, NEC, neonates, preterm

Brief summary

Hypothesis: Controlled hypothermia to 33.5C for 48 hours reduces the severity of critical illness in neonates with severe necrotizing enterocolitis.

Interventions

PROCEDUREcooling blanket/mattress

Therapeutic controlled hypothermia (33.5C) using cooling blanket/mattress

PROCEDUREStandard treatment of care at normothermia

Standard treatment of care in 33.5C for 48 hours

Sponsors

Great Ormond Street Hospital for Children NHS Foundation Trust
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Healthy volunteers
No

Inclusion criteria

* weight at diagnosis \> 700 grams * confirmed NEC (Bell's stage II or III) * radiological evidence of pneumatosis coli * systemic compromise as defined by increase in ventilation requirement and/or requiring inotopic support

Design outcomes

Primary

MeasureTime frameDescription
Difference in sequential organ failure assessment (SOFA) score5 daysDifference in sequential organ failure assessment (SOFA) score at 5 days after intervention

Secondary

MeasureTime frameDescription
Baseline time taken to establish full enteral feeds5 daysTime to establish full enteral feeds and organ functional investigation and biomarkers at baseline, 24 hours post, 63 hours post and day 5 post intervention
Neurodevelopmental Assessment24 monthsNeurodevelopmental outcome with MRI at term corrected age and neurodevelopmental assessment at 3, 6,12 and 24 months and mortality data

Countries

United Kingdom

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026